Cargando…
Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle East Respiratory Syndrome Coronavirus
BACKGROUND: REGN3048 and REGN3051 are human monoclonal antibodies (mAb) targeting the spike glycoprotein on the Middle East respiratory syndrome coronavirus (MERS-CoV), which binds to the receptor dipeptidyl peptidase-4 (DPP4) and is necessary for infection of susceptible cells. METHODS: Preclinical...
Autores principales: | Sivapalasingam, Sumathi, Saviolakis, George A, Kulcsar, Kirsten, Nakamura, Aya, Conrad, Thomas, Hassanein, Mohamed, Sumner, Giane, Elango, Chinnasamy, Kamal, Mohamed A, Eng, Simon, Kyratsous, Christos A, Musser, Bret J, Frieman, Matthew, Kantrowitz, Joel, Weinreich, David M, Yancopoulos, George, Stahl, Neil, Lipsich, Leah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928873/ https://www.ncbi.nlm.nih.gov/pubmed/33507266 http://dx.doi.org/10.1093/infdis/jiab036 |
Ejemplares similares
-
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
por: Weinreich, David M., et al.
Publicado: (2020) -
A drug‐disease model for predicting survival in an Ebola outbreak
por: Toroghi, Masood Khaksar, et al.
Publicado: (2022) -
REGEN-COV(®) antibody cocktail bioanalytical strategy: comparison of LC-MRM-MS and immunoassay methods for drug quantification
por: Irvin, Susan C, et al.
Publicado: (2021) -
Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants
por: Simões, Eric A F, et al.
Publicado: (2020) -
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
por: Hansen, Johanna, et al.
Publicado: (2020)